Switzerland

Switzerland

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide.

Gilead’s office in Zug is responsible for medical, sales and marketing activities for our products in Switzerland.

Relationships with Charitable Organizations

Gilead provided support for the following charitable organizations in 2012, via unrestricted educational grants. The information is correct at the time of writing (March 2013). The information is subject to change and will be updated accordingly.

• Grant Recipient
  Description of Activity
  Amount Funded €
• Aids-Hilfe Schweiz
  Congress participation: WAIDS - 19th International AIDS Conference
  9180
• Aids-Hilfe Schweiz
  Project: Mediator Training (“HIV & Your Body”) on the topics of “HIV & Schwangerschaft” and “HIV & Lipodystrophie”
  1200
• Aids-Hilfe Schweiz
  Project: Therapie Broschüre für Menschen mit HIV
  6000
• Aids-Hilfe Schweiz
  Project: Beitrag "Swiss Aids News"
  12000
• Aids-Hilfe Schweiz
  Consulting: HIV talk at 5th anniversary of Gilead Switzerland
  1200
• Groupe SIDA
  Congress participation: International Symposium HIV & Emerging Infectious Diseases
  600
• Positivrat
  Congress participation: WAIDS - 19th International AIDS Conference
  1000
• Positivrat
  Consulting: HIV talk at 5th anniversary of Gilead Switzerland
  1200
• Positivrat
  Sponsoring various projects
  19800
• Positivrat
  Education: "HIV and your healthy ageing body" train the trainer
  5600
• Check Point
  Project: Stoos Workshop weekend für HIV-Neudiagnostizierte Männer und ihre Partner
  6000
• Schweizerische Gesellschaft für Cystische Fibrose
  Support of annual meeting 2012, advert in CF-Bulletin and website cfch.ch
  9000
• Schweizerische Gesellschaft für Cystische Fibrose
  Project: New edition of "Cystische Fibrose" brochure
  6000